risedronic acid has been researched along with Otospongiosis in 3 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Excerpt | Relevance | Reference |
---|---|---|
"Otosclerosis is a disease of abnormal bone remodeling in the otic capsule." | 1.38 | Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis. ( Halpin, C; McKenna, MJ; Merchant, SN; Quesnel, AM; Seton, M, 2012) |
"Otosclerosis is a bony dyscrasia characterized by histopathological findings of osteoclast production." | 1.35 | Medical treatment of otosclerosis: rationale for use of bisphosphonates. ( Brookler, K, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brookler, K | 1 |
Brookler, KH | 1 |
Quesnel, AM | 1 |
Seton, M | 1 |
Merchant, SN | 1 |
Halpin, C | 1 |
McKenna, MJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effects of Bisphosphonates on OI-Related Hearing Loss: A Pilot Study[NCT04152551] | Phase 4 | 100 participants (Anticipated) | Interventional | 2019-11-02 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 other studies available for risedronic acid and Otospongiosis
Article | Year |
---|---|
Medical treatment of otosclerosis: rationale for use of bisphosphonates.
Topics: Aged; Alendronate; Animals; Bone Density Conservation Agents; Bone Resorption; Cell Death; Combined | 2008 |
Monaural diplacusis with tinnitus, aural fullness, hyperacusis, and sensorineural hearing loss.
Topics: Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Etidronic Acid; Hearing Loss, Sensorine | 2009 |
Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis.
Topics: Adult; Aged; Audiometry, Pure-Tone; Auditory Threshold; Bone Conduction; Bone Density Conservation A | 2012 |